Hikma Pharmaceuticals
| Company type | Public |
|---|---|
| Industry | Pharmaceutical |
| Founded | 1978 Jordan |
| Founder | Samih Darwazah |
| Headquarters | London, England, UK |
Key people | |
| Products | Amoclan Prograf Suprax |
| Revenue | US$3,349 million (2025) |
| US$741 million (2025) | |
| US$407 million (2025) | |
Number of employees | 9,500 (2026) |
| Website | www |
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.